Literature DB >> 3789178

Cardiovascular actions of vasopressin: baroreflex modulation in the conscious rat.

R L Webb, J W Osborn, A W Cowley.   

Abstract

Mean arterial pressure (MAP), heart rate (HR), cardiac output (CO), and total peripheral resistance (TPR) were recorded during graded infusions of arginine vasopressin (AVP), angiotensin II (ANG II), and phenylephrine (PE) in conscious, unrestrained, sinoaortic-denervated (SAD) and normal rats. Base-line MAP, CO, and TPR values before infusion were not different between groups. HR values were significantly higher in SAD rats. Dose-response curves indicated that there was a similar enhancement in pressor sensitivity to AVP, ANG II, and PE in the absence of the baroreceptors. Pressor responses to AVP were buffered by offsetting decreases of CO. Similar elevations in MAP evoked a 50% greater reduction in CO with AVP, and HR decreased 1.5 times as much with AVP than with ANG II or PE. The dose of AVP required to raise MAP by 25 mmHg in control rats resulted in similar falls of CO in SAD rats, whereas HR responses to AVP were attenuated significantly in SAD rats. We conclude that baroreceptor buffering of AVP-induced pressor responses is due principally to reflex reduction of TPR. Furthermore, CO suppression was not baroreflex-mediated, whereas bradycardia was reflex dependent. Finally, in rats, AVP does not appear to interact with the baroreceptor reflexes in a manner unique from other vasoconstrictor agents to buffer MAP.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3789178     DOI: 10.1152/ajpheart.1986.251.6.H1244

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  8 in total

1.  Regional haemodynamic effect of vasopressin infusion in conscious, unrestrained, Brattleboro rats.

Authors:  S M Gardiner; A M Compton; T Bennett
Journal:  Br J Pharmacol       Date:  1989-05       Impact factor: 8.739

2.  Adverse effect of therapeutic vasoconstrictors in experimental acute pancreatitis.

Authors:  E Klar; D W Rattner; C Compton; G Stanford; B Chernow; A L Warshaw
Journal:  Ann Surg       Date:  1991-08       Impact factor: 12.969

3.  The influence of atropine and atenolol on the cardiac haemodynamic effects of NG-nitro-L-arginine methyl ester in conscious, Long Evans rats.

Authors:  R E Widdop; S M Gardiner; P A Kemp; T Bennett
Journal:  Br J Pharmacol       Date:  1992-03       Impact factor: 8.739

4.  Stimulation of the ventral tegmental area enhances the effect of vasopressin on blood pressure in conscious rats.

Authors:  M van Den Buuse; R Catanzariti
Journal:  Br J Pharmacol       Date:  2000-01       Impact factor: 8.739

Review 5.  Role of vasopressin in the management of septic shock.

Authors:  Gökhan M Mutlu; Phillip Factor
Journal:  Intensive Care Med       Date:  2004-04-21       Impact factor: 17.440

6.  Cardiac and peripheral circulatory responses to angiotension and vasopressin in dogs.

Authors:  R W Lee; S Standaert; L D Lancaster; D Buckley; S Goldman
Journal:  J Clin Invest       Date:  1988-08       Impact factor: 14.808

7.  Next-generation hypomethylating agent SGI-110 primes acute myeloid leukemia cells to IAP antagonist by activating extrinsic and intrinsic apoptosis pathways.

Authors:  Jessica Dittmann; Tinka Haydn; Patrick Metzger; George A Ward; Melanie Boerries; Meike Vogler; Simone Fulda
Journal:  Cell Death Differ       Date:  2019-12-12       Impact factor: 15.828

8.  The effects of terlipressin on regional hemodynamics and kidney function in experimental hyperdynamic sepsis.

Authors:  Ken Ishikawa; Li Wan; Paolo Calzavacca; Rinaldo Bellomo; Michael Bailey; Clive N May
Journal:  PLoS One       Date:  2012-02-15       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.